Skip to main content


At Neurelis, we approach things a little differently. Our commitment to the communities we serve is personal. Our spirit is tenacious. We are inspired by the resilience of the people we serve. Our relentless pursuit is to innovate life-changing treatments that empower people to define their neu normal. We never stop––because there is always more to be done.

Neurelis was founded to license, develop, and commercialize product candidates for the broader central nervous system (CNS), including epilepsy and psychiatry. Our emphasis is on highly differentiated therapies that empower people with neurological conditions, care partners, and healthcare providers. The benefits of our unique platform technology allow us to form strategic partnerships to address significant unmet needs in other therapeutic areas as well.


The Neurelis team has a rich history of relevant neurology industry experience.

Meet the Leadership Team
Meet the Board of Directors